Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CABA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
140 filers reported a long position in CABA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| JENNISON ASSOCIATES LLC | $62.3M | 20M | +123.3% |
| T. Rowe Price Investment Management, Inc. | $58.7M | 18.9M | +70.3% |
| Bain Capital Life Sciences Investors, LLC | $53.6M | 17.2M | +78.2% |
| BlackRock, Inc. | $33.4M | 10.8M | +353.2% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $28.5M | 9.2M | +3.9% |
| STATE STREET CORP | $24.4M | 7.8M | +1,568% |
| VANGUARD CAPITAL MANAGEMENT LLC | $22.5M | 7.2M | +79.4% |
| Cormorant Asset Management, LP | $15.6M | 5M | -9.1% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $13.7M | 4.4M | +899.1% |
| Woodline Partners LP | $13.1M | 4.2M | +235.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.